Dry ice machines orders from US up

As Trump hails launch of COVID19 vaccines, makers of dry ice and related machines in China working in full swing to respond to soaring demand for cold chain, with some firms’ orders from US up 10-20 times y-o-y.

The ultra-cold temperatures required for storing the Covid-19 vaccine developed by U.S. pharmaceutical giant Pfizer and Germany-based BioNTech has driven a buying frenzy for freezers and dry ice. However, large-scale freezers units are expensive — and with hospital budgets already strained during the pandemic, dry ice has emerged as the go-to option. Thank you, Trump!

Bahrain approves Sinopharm’s COVID-19 vaccine

12-13-20 Bahraini government has registered a COVID19 vaccine developed by Chinese producer CNBG after reviewing its phase 3 clinical trial data that shows 86% efficacy rate, and 100% efficacy in preventing medium and severe symptoms.
CNBG, a subsidiary of Sinopharm, said Sat that it expects to produce 1 billion doses of COVID19 vaccine next year. So far, it has carried out phase III clinical trials in 10 countries and regions worldwide on 60,000 subjects.

Climate Ambition Summit

In a speech delivered on Saturday at the Climate Ambition Summit, Chinese President Xi Jinping made three proposals:

1. to close ranks and make new advances in climate governance that features cooperation and win-win;
2. to raise ambition and foster a new architecture of climate governance where every party does its part; and

3. to boost confidence and pursue a new approach to climate governance that highlights green recovery.

China will lower its carbon dioxide emissions per unit of GDP by over 65 percent from the 2005 level, and increase the share of non-fossil fuels in primary energy consumption to around 25 percent.
China will increase its forest stock volume by 6 billion cubic meters from the 2005 level, and bring its total installed capacity of wind and solar power to over 1.2 billion kilowatts